Workflow
市净率
icon
Search documents
通源环境:预计2025年亏损3200万元-4200万元
Core Viewpoint - The company Zhongzheng Intelligent Environmental (688679) expects a significant loss in 2025, with a projected net profit loss of 32 million to 42 million yuan, compared to a profit of 21.75 million yuan in the previous year [4]. Financial Performance - The forecasted net profit loss for 2025 is between 32 million and 42 million yuan, while the non-recurring net profit loss is expected to be between 34 million and 44 million yuan, compared to profits of 18.77 million yuan in the previous year [4]. - The company's price-to-book ratio (P/B) is approximately 6.41 times, and the price-to-sales ratio (P/S) is about 4.99 times based on the latest closing price [4]. - Historical net profit and non-recurring net profit figures show a downward trend, with the projected net profit for 2025 indicating a significant decline compared to previous years [15]. Industry Context - The company operates in the solid waste pollution control, resource recovery, sewage and water environment management, and soil and groundwater remediation sectors, which are facing intensified market competition [14]. - The decline in revenue and gross profit margins is attributed to increased competition within the industry [14]. - Management expenses have risen due to increased fixed asset depreciation, and investment income has decreased due to significant losses from associated companies [14].
利和兴:预计2025年亏损1.2亿元-1.7亿元
Group 1 - The company Lihexing (301013) expects a net loss attributable to shareholders of 120 million to 170 million yuan for the year 2025, compared to a profit of 7.08 million yuan in the same period last year [4] - The company's non-recurring net profit is projected to be a loss of 117 million to 167 million yuan, down from a profit of 3.81 million yuan in the previous year [4] - The company's price-to-book ratio (LF) is approximately 8.34 times, and the price-to-sales ratio (TTM) is about 11.73 times based on the latest closing price [4] Group 2 - The company's performance decline is attributed to a drop in operating revenue and gross margin, particularly in the smart equipment business due to fluctuating customer demand and intensified market competition [14] - Although the electronic components business saw a slight increase in sales revenue compared to the previous year, the growth rate was relatively slow, and the gross margin was negative due to low industry sales prices and underutilization of production capacity [14] - The company plans to recognize credit impairment losses and asset impairment losses totaling approximately 47 million yuan, in accordance with accounting standards and financial management regulations [14]
江山欧派:预计2025年亏损1.8亿元-2.3亿元
Core Viewpoint - The company Jiangshan Oupai (603208) has announced a significant decline in its financial performance for the year 2025, projecting a revenue of 1.6 billion yuan and a net loss of 180 million to 230 million yuan, compared to a profit of 109 million yuan in the previous year [2]. Financial Performance Summary - The projected revenue for 2025 is approximately 1.6 billion yuan [11]. - The expected net loss for 2025 ranges from 180 million to 230 million yuan, a stark contrast to the profit of 109 million yuan in the previous year [11]. - The projected non-recurring net loss for 2025 is estimated between 220 million to 270 million yuan, compared to a profit of 7.12 million yuan in the previous year [2][11]. - The company's price-to-book ratio (LF) is approximately 2.25 times, and the price-to-sales ratio (TTM) is about 1.69 times based on the latest closing price [2]. Reasons for Performance Decline - The overall market downturn and shrinking demand in the industry have led to a decrease in revenue, compounded by a reduction in direct sales receivables [11]. - Intense industry competition has resulted in price adjustments for some products, leading to a decline in gross margin [11]. - Fixed costs such as depreciation and personnel expenses have not decreased in line with the revenue drop, causing further financial strain [11]. - The company has conducted a comprehensive review of its assets and has made provisions for asset impairment totaling approximately 200 million yuan [11].
尚荣医疗:预计2025年亏损1.2亿元-1.7亿元
Sou Hu Cai Jing· 2026-01-23 11:26
Group 1 - The company operates in the medical products, medical services, and health industry sectors [7] - The company's performance has been negatively impacted by a decrease in hospital engineering projects due to industry conditions, leading to a reduction in medical engineering service revenue [7] - The company has increased its provision for bad debts due to lower-than-expected hospital project payments [7] Group 2 - The export business of medical consumables has faced challenges due to international circumstances, resulting in decreased revenue and increased costs, which have led to a decline in gross profit margin [7] - Currency fluctuations have contributed to an increase in exchange losses recognized by the company [7] - The company has also increased its asset impairment provisions during the reporting period [7] Group 3 - Historical net profit and non-recurring profit growth rates show significant fluctuations, with a notable decline in 2022 and projections for 2023 indicating continued challenges [10] - The company's net profit and non-recurring profit have shown negative trends in quarterly changes, indicating ongoing financial difficulties [10]
新强联:预计2025年净利同比增长1093.07%-1307.21%
Core Viewpoint - The company Xinqianglian (300850) has announced its earnings forecast for 2025, projecting a significant increase in net profit and non-recurring net profit, driven by the recovery in the wind power industry and improved cost management [4]. Group 1: Earnings Forecast - The company expects a net profit attributable to shareholders of 780 million to 920 million yuan for 2025, representing a year-on-year growth of 1093.07% to 1307.21% [4]. - The forecast for non-recurring net profit is between 680 million to 820 million yuan, indicating a year-on-year increase of 356.18% to 450.1% [4]. Group 2: Valuation Metrics - As of January 23, the company's price-to-earnings ratio (TTM) is approximately 22.37 to 26.38 times, with a price-to-book ratio (LF) of about 3 times and a price-to-sales ratio (TTM) of around 4.48 times [4]. - Historical earnings data shows a significant increase in both net profit and non-recurring net profit over the years, with projections for 2025 indicating a continued upward trend [5]. Group 3: Business Operations - The company's main business includes the design and manufacturing of large slewing bearings, precision bearings, and related components, which have benefited from increased demand in the wind power sector [4]. - The company has managed to expand its market share by leveraging its technological advantages and optimizing cost control, leading to a steady increase in product gross margins [4].
济民健康:预计2025年亏损2.1亿元-2.5亿元
Core Viewpoint - The company Jimin Health (603222) has announced a forecast for a net loss of 210 million to 250 million yuan for the year 2025, compared to a loss of 59.71 million yuan in the previous year [4] Financial Performance - The expected net profit loss for 2025 is between 210 million and 250 million yuan, with a non-recurring net profit loss estimated at 205 million to 245 million yuan, compared to a loss of 58.69 million yuan in the previous year [4] - The company's price-to-book ratio (LF) is approximately 3.55 times, and the price-to-sales ratio (TTM) is about 7.78 times based on the latest closing price [4] Business Impact Factors - The company's revenue has declined further due to factors such as U.S. tariff policies and the "He Qinghong stamp forgery incident," leading to increased losses [15] - The company has made provisions for inventory impairment of approximately 37 million yuan for pre-filled catheter flushing devices and safety syringes [15] - Losses related to the "He Qinghong and others forging company seals" case have been confirmed at around 38 million yuan [15] - The performance of Ezhou Second Hospital has declined compared to the previous year, prompting the company to make a goodwill impairment provision of approximately 20 million yuan [15]
农发种业:预计2025年净利同比增长59.96%-79.15%
Group 1 - The company, Nongfa Seed Industry (600313), forecasts a net profit attributable to shareholders of 75 million to 84 million yuan for 2025, representing a year-on-year increase of 59.96% to 79.15% [2] - The company expects a non-recurring net profit of 19.19 million to 28.19 million yuan, recovering from a loss of 27.516 million yuan in the same period last year [2] - As of January 23, the company's price-to-earnings ratio (TTM) is approximately 87.35 to 97.83 times, with a price-to-book ratio (LF) of about 3.72 times and a price-to-sales ratio (TTM) of about 1.18 times [2] Group 2 - The company's main business includes the research, production, and sales of crop seeds, production and sales of pesticide products, fertilizer trading, and specialty grain order business [6] - The increase in performance is attributed to several factors: expansion of sales channels in the seed business, significant growth in revenue and profit in the fertilizer business due to active sourcing of imports, and improved market share in the pesticide business through enhanced production processes and cost reduction measures [6]
南京银行:2025年净利218.07亿元 同比增长8.08%
公司 -{○- 行业均值 中证智能财讯南京银行(601009)1月22日晚间披露2025年业绩快报,公司实现营业收入555.4亿元,同比增长10.48%;归母净利润218.07亿元,同比增长 8.08%;扣非净利润216.78亿元,同比增长8.73%;基本每股收益1.76元,加权平均净资产收益率为12.04%。以1月22日收盘价计算,南京银行目前市盈率 (TTM)约为5.91倍,市净率(LF)约0.72倍,市销率(TTM)约2.4倍。 以本次披露业绩快报数据计算,公司近年市盈率(TTM)图如下所示: 近年来市盈率变化情况(倍) 8 (倍) 6.39 6 5.84 Act 4 4 38 2 0 2021-06-30 | 2020-12-37 I 2027-12-37 1 2022-06-30 1 2022-72-37 1 J23-06-30 2024-06-30 23-12-37 203 100 ହ 90 80 70 62.5 60 50 40 38.84 39808 30 24,93 24:48 2103 20 10 0 2027-12-37 | 2022-12-37 1 2020-12-37 1 202-0 ...
青松股份:预计2025年净利同比增长137.73%-201.74%
Core Viewpoint - Qingsong Co., Ltd. (青松股份) expects significant growth in its 2025 performance, with projected revenue and net profit showing substantial year-on-year increases [4]. Financial Performance - The company anticipates a revenue of 2.218 billion yuan in 2025, representing a year-on-year growth of 14.34% [4]. - The expected net profit attributable to shareholders is between 130 million yuan and 165 million yuan, indicating a year-on-year increase of 137.73% to 201.74% [4]. - The forecasted net profit excluding non-recurring items is estimated to be between 96 million yuan and 131 million yuan, reflecting a growth of 73.29% to 136.47% year-on-year [4]. Valuation Metrics - As of January 22, the company's price-to-earnings ratio (TTM) is approximately between 29.05 and 36.88 times, with a price-to-book ratio (LF) of about 3.4 times and a price-to-sales ratio (TTM) of around 2.16 times [4]. - Historical price-to-earnings ratio trends indicate fluctuations over recent years, with the company’s TTM P/E ratio showing a range from 20 to 41 times [5][6]. Industry Context - The overall consumption in the domestic cosmetics industry is experiencing a steady recovery, which has positively impacted customer order demand for the company [13]. - The company’s performance improvement is also attributed to the completion of a land project disposal, which is expected to contribute approximately 34 million yuan to the net profit [13].
博通集成:预计2025年盈利1718.93万元-2578.39万元 同比扭亏
Core Viewpoint - The company, Broadcom Integrated (603068), has announced a profit forecast for 2025, expecting a net profit attributable to shareholders between 17.19 million and 25.78 million yuan, a significant recovery from a loss of 24.72 million yuan in the previous year [4]. Financial Performance - The company anticipates a non-recurring loss between 23.16 million and 31.76 million yuan, compared to a loss of 42.78 million yuan in the same period last year [4]. - The expected net profit margin indicates a turnaround in the company's financial health, driven by increased operating income and improved operational efficiency [14]. Valuation Metrics - As of January 22, the company's price-to-earnings (P/E) ratio (TTM) is approximately between 232.9 and 349.34 times, with a price-to-book (P/B) ratio (LF) of about 3.57 times and a price-to-sales (P/S) ratio (TTM) of around 6.85 times [4]. - The historical P/E ratio shows significant fluctuations, reflecting the company's past performance and market conditions [5][6]. Business Overview - The company's main business involves the research and sales of wireless communication integrated circuit chips [14]. - The improvement in financial performance is attributed to better operational conditions, increased revenue, and a reduction in period expenses, alongside non-recurring gains of approximately 49 million yuan from government subsidies and asset disposals [14].